AstraZeneca’s move to upgrade its listing in the U.S. risks pulling liquidity away from London’s stock market and could pave ...

AstraZeneca’s move to upgrade its listing in the U.S. risks pulling liquidity away from London’s stock market and could pave ...

AstraZeneca laid out plans on Monday to switch to a direct listing of its shares in the United States, as the drugmaker seeks ...

AstraZeneca said on Friday it will sell its diabetes and asthma drugs direct to cash-paying U.S. patients at a discount of up ...

The British company said the direct listing would replace the existing listing of its American depository receipts on the ...

AstraZeneca saw its share prices jump to a new all-time high on Wednesday, as investors cheered reports that President Donald ...

AstraZeneca shares rallied on Wednesday after the U.K. giant and its Japanese partner said the Food and Drug Administration ...

The PPD™ clinical research business of Thermo Fisher Scientific, the world leader in serving science, today announced a new ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

AstraZeneca has announced plans to list shares on the New York Stock Exchange, stoking fears that Britain’s biggest drugmaker ...

Amid the spat, AstraZeneca has already paused investments in the UK, and announced it would pour $50bn into the US by 2030. A ...

AstraZeneca plans direct listing on New York Stock Exchange AstraZeneca to list directly in New York while keeping London ...